Pandemic H1N1 Influenza Vaccine Quick Reference Guide
QUICK REFERENCE GUIDE FOR SCHOOL-BASED HPV IMMUNIZATIONS
Manitoba Eligibility Criteria for Publicly Funded Vaccines: As of March 31, 2014 all females in Grade 6, and females who missed the vaccine in grade 6 who were born on or after January 1’st 1997 are eligible to receive the publically funded HPV series. Females with increased risk of HPV infection who started the 3 dose vaccine series before March 31st, 2014 will be eligible to finish the series free of charge.
|Trade Name/ Manufacturer Description |Contents |Supplied |
|Gardasil® |Active ingredients: |Gardasil® supplied in single dose |
|Merck Canada |Prepared from the highly purified virus-like particles (VLPs) of the recombinant major capsid (L1) protein of HPV |glass vials |
|Quadrivalent Human Papillomavirus (Types 6, 11, 16, |Types 6, 11, 16, and 18. The L1 proteins are | |
|18) Recombinant Vaccine |produced by separate fermentations in recombinant Saccharomyces cerevisiae (yeast) and self-assembled into VLPs. The |Gardasil® is a white, cloudy |
| |vaccine contains yeast protein. |liquid. |
| |Inactive Ingredients: | |
| |Adjuvant: | |
| |aluminum (as amorphous aluminum hydroxyphosphate sulfate [AAHS]) | |
| |Other ingredients: | |
| |sodium chloride, L-histidine, polysorbate 80, sodium borate, water for injection. This product is latex free; no | |
| |preservatives or antibiotics. | |
Store refrigerated at 2°C to 8°C. Do not freeze. Protect from light. Shake well before use, after thorough agitation.
|Age |Dose / Schedule |Route |
| | |Needle Gauge / Length |
|Gardasil vaccine is approved for use in females ages |0.5 mL |IM (deltoid) |
|9- 45 years of age; and men 9 – 26 yrs. |Recommended schedule: | |
| |Preferred schedule is 0, 2 and 6 months1 |1- 1 ½ ” |
| | |22-25 G |
1The preferred schedule is 0, 2, & 6 months. The minimum interval between the first and second dose is 1 month. The second and third doses should be separated by an interval of at least 12 weeks. (Canadian Immunization Guide Evergreen Edition at:
Source: Product Monograph Merck Canada May 15, 2013 at:
& MHHL Document “Human Papilloma Virus Information for Health Professionals” January 2013 at:
Canadian Immunization Guide Evergreen Ed. @
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- influenza vaccine products for 2019 2020
- influenza vaccine 2019 2020
- cdc influenza vaccine 2019
- cdc influenza vaccine 2019 2020
- influenza vaccine code 2019 medicare
- 2019 influenza vaccine cpt codes
- sba quick reference guide 2019
- influenza vaccine 2019 2020 cpt codes
- influenza vaccine components 2019
- influenza vaccine sanofi pasteur
- sanofi influenza vaccine package insert
- sanofi pasteur influenza vaccine portfolio